← Back to Intel
Insider ActivityZVRA
Bode John B, Director at ZEVRA THERAPEUTICS, INC., traded $195K of ZVRA
Updated Jun 12, 2026
Bode John B
Director
ZEVRA THERAPEUTICS, INC. ·
$ZVRA
Transaction Details
| Insider | Bode John B |
|---|---|
| Title | Director |
| Company | ZEVRA THERAPEUTICS, INC. |
| Ticker | ZVRA |
| Transaction Type | Exercise |
| Transaction Date | 2026-03-24 |
| Shares Traded | 39,200 |
| Price Per Share | $4.97 |
| Total Value | $195K |
| Filed Date | 2026-03-26 |
| Accession Number | 0001612084-26-000002 |
Ownership Context
| Shares Owned After Transaction | 84,200 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001612084-26-000002
Other Insider Trades — ZVRA
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Sangiovanni Timothy J. | SVP, Finance & Corp Controller | traded | — | 2026-05-28 |
| Sangiovanni Timothy J. | SVP, Finance & Corp Controller | traded | — | 2026-05-28 |
| Thompson Rahsaan | Chief Legal & Compliance | sold | $20K | 2026-05-11 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ZVRA — ZEVRA THERAPEUTICS, INC. →
Track ZVRA insider activity in real time on The Wire →
Get alerts when Bode John B files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 12, 2026 at 07:16 UTC